TTK Healthcare Limited (BOM: 507747)

Market Cap	20.23B
Revenue (ttm)	7.71B
Net Income (ttm)	799.43M
Shares Out	14.13M
EPS (ttm)	56.57
PE Ratio	25.31
Forward PE	n/a
Dividend	10.00 (0.70%)
Ex-Dividend Date	Jul 16, 2024

Volume	186
Open	1,431.55
Previous Close	1,422.75
Day's Range	1,395.55 - 1,431.85
52-Week Range	1,232.05 - 1,923.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Human Pharma, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, anti-parasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pe...

• Industry: Pharmaceutical Preparations
• Founded: 1928
• Employees: 1,316
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507747

Financial Performance

In 2023, TTK Healthcare's revenue was 7.53 billion, an increase of 3.82% compared to the previous year's 7.25 billion. Earnings were 628.42 million, a decrease of -90.18%.